--- title: "Switching from Wegovy to Zepbound: Guide" description: "Switching from Wegovy to Zepbound usually means a clinician restarts titration and times the first dose to reduce side effects, with clinician guidance." canonical: "https://www.vitalsvault.com/treatment-learn/switching-from-zepbound-to-wegovy" last-updated: 2026-08-22 --- # Switching from Wegovy to Zepbound: Guide > Switching from Wegovy to Zepbound usually means a clinician restarts titration and times the first dose to reduce side effects, with clinician guidance. Ask AI for a summary [![Claude](https://www.vitalsvault.com/ai-icon/claude.svg)](https://claude.ai/new?q=Summarize+this+article.+https%3A%2F%2Fwww.vitalsvault.com%2Ftreatment-learn%2Fswitching-from-zepbound-to-wegovy)[![Google AI](https://www.vitalsvault.com/ai-icon/google.svg)](https://www.google.com/search?q=Summarize+this+article.+https%3A%2F%2Fwww.vitalsvault.com%2Ftreatment-learn%2Fswitching-from-zepbound-to-wegovy&udm=50)[![Grok](https://www.vitalsvault.com/ai-icon/grok.svg)](https://x.com/i/grok?text=Summarize+this+article.+https%3A%2F%2Fwww.vitalsvault.com%2Ftreatment-learn%2Fswitching-from-zepbound-to-wegovy)[![ChatGPT](https://www.vitalsvault.com/ai-icon/openai.svg)](https://chat.openai.com/?q=Summarize+this+article.+https%3A%2F%2Fwww.vitalsvault.com%2Ftreatment-learn%2Fswitching-from-zepbound-to-wegovy)[![Perplexity](https://www.vitalsvault.com/ai-icon/perplexity.svg)](https://www.perplexity.ai/search/new?q=Summarize+this+article.+https%3A%2F%2Fwww.vitalsvault.com%2Ftreatment-learn%2Fswitching-from-zepbound-to-wegovy) ![switching from wegovy to zepbound medication](https://static.vitalsvault.com/medications/care-tirzepatide/listing-v1.png) ![switching from wegovy to zepbound treatment option](https://www.vitalsvault.com/_next/image?url=https%3A%2F%2Fstatic.vitalsvault.com%2Fmedications%2Fcare-tirzepatide%2Flisting-v1.png&w=3840&q=75) Treatment options ## See if tirzepatide fits A qualified clinician must determine whether a prescription treatment is appropriate for you. [See if you qualify](https://treatments.vitalsvault.com/treatments/care-tirzepatide) Switching from wegovy to zepbound can make sense if you are not tolerating side effects, your goals have changed, or your clinician thinks a different GLP-1 based option fits your health history better. Because these medicines have different active ingredients, most people do not switch dose for dose. This guide explains how clinicians typically plan a safe transition and what to watch for. Vitals Vault can also connect you with clinician guided care, but the decision to switch and the starting dose should be individualized. - Switching from wegovy to zepbound is usually done by restarting titration under clinician guidance. - Your clinician often times the first dose around your last injection to limit nausea and vomiting. - Do not use both medicines together unless a prescriber specifically directs it. - Know urgent warning signs: severe belly pain, dehydration, allergic reaction, or possible low blood sugar. ## When you might switch - ### Side effects on semaglutide If nausea, vomiting, constipation, or reflux are limiting your day to day life, your clinician may consider a different medicine or a slower titration. Both semaglutide and tirzepatide can cause gastrointestinal side effects, but individual tolerance varies. Any switch should be planned to reduce dehydration and kidney stress. - ### Different medical priorities Tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide is a GLP-1 receptor agonist. Your clinician may weigh factors like diabetes status, other medications, and prior response when choosing between them. The goal is a regimen you can take consistently and safely. - ### Access or coverage changes Insurance coverage, pharmacy availability, and prior authorization rules can change. If you are switching because of access, ask your clinician about timing so you do not have long gaps or overlap. Do not try to stretch doses or combine products without prescriber direction. ## How clinicians plan the switch - ### No direct dose conversion There is not a single official conversion chart between Wegovy (semaglutide) and Zepbound (tirzepatide). Each product has its own titration schedule in the FDA prescribing information, and clinicians commonly restart at a lower dose and titrate based on tolerance. This helps reduce nausea, vomiting, and diarrhea during the transition. - ### Timing around the last injection Both medicines are designed for once weekly dosing, and clinicians often schedule the first dose of the new medicine around the time the next dose would have been due. The exact timing can vary based on side effects, missed doses, and other medications. Your prescriber may also advise a longer gap if you had significant gastrointestinal symptoms. - ### Medication review matters Your clinician should review other medicines that can affect blood sugar, especially insulin or sulfonylureas, because GLP-1 based therapies can increase the risk of low blood sugar when used with those drugs. They should also review your history of pancreatitis, gallbladder disease, kidney problems, and thyroid cancer risk factors. Bring a full list of prescriptions, over the counter drugs, and supplements. - ### Compounded products are different If you are using compounded semaglutide or compounded tirzepatide, the exact formulation and instructions come from the prescribing clinician and dispensing pharmacy. Compounded medications are prepared by a licensed pharmacy for an individual prescription and are not FDA-approved. Ask for clear written directions and what to do if you miss a dose. ### About brand names and compounded care Zepbound is a brand product. Vitals Vault offers Tirzepatide (compounded, injectable) as a compounded medication, not Zepbound. Wegovy is a brand product. Vitals Vault offers Semaglutide (compounded, injectable) as a compounded medication, not Wegovy. ## What to expect after switching - ### A new titration period Even if you were on a higher dose of semaglutide, you may be started at a lower tirzepatide dose and increased gradually. During titration, gastrointestinal side effects are often the main limiting factor. Your clinician may adjust the pace based on how you feel and whether you are able to eat and drink normally. - ### Temporary appetite changes Many people notice appetite and fullness change when starting or switching GLP-1 based medicines. Early changes do not always predict how you will feel after you reach a stable maintenance dose. Track symptoms like nausea, reflux, constipation, and fatigue so you can report patterns to your clinician. - ### Monitoring for dehydration Vomiting or diarrhea can lead to dehydration, which can worsen kidney function. If you cannot keep fluids down, or you have dizziness, fainting, or very dark urine, contact a clinician promptly. This is especially important if you take diuretics or have kidney disease. ## Side effects and safety points Key safety issues to review before switching | Issue | Why it matters when switching | What to do | | --- | --- | --- | | Thyroid C-cell tumor warning | Both semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors in rodents and are contraindicated with personal or family history of medullary thyroid carcinoma or MEN 2. | Tell your clinician about any thyroid cancer history and neck mass or hoarseness symptoms. | | Pancreatitis | Acute pancreatitis has been reported with GLP-1 receptor agonists; labels advise stopping if pancreatitis is suspected. | Seek urgent care for severe, persistent abdominal pain that may radiate to the back. | | Gallbladder disease | Gallbladder problems including cholelithiasis and cholecystitis have been reported with GLP-1 based therapies. | Contact a clinician for right upper belly pain, fever, or yellowing of skin or eyes. | | Kidney injury from dehydration | Nausea, vomiting, and diarrhea can lead to dehydration and worsen kidney function. | Get help if you cannot keep fluids down or have signs of dehydration. | | Low blood sugar with certain drugs | Risk is higher if you use insulin or sulfonylureas along with GLP-1 based medicines. | Review diabetes medicines with your prescriber and know low blood sugar symptoms. | - ### Common GI effects Nausea, vomiting, diarrhea, constipation, and abdominal pain are among the most common side effects for both medicines. These are often dose related and more likely during titration. Eating smaller meals and avoiding high fat meals may help, but discuss persistent symptoms with your clinician. - ### Severe allergic reaction Stop using the medicine and get emergency help if you have swelling of the face, lips, tongue, or throat, trouble breathing, or widespread rash. Hypersensitivity reactions are listed in prescribing information. Tell your clinician about any prior reactions to injectable medicines. - ### Severe stomach problems Persistent vomiting, inability to keep liquids down, or severe abdominal pain needs prompt medical evaluation. These symptoms can signal dehydration, pancreatitis, or other complications. Do not take another dose until you have been evaluated and advised by a clinician. ## Questions to ask your clinician 1. 1 ### Ask about timing Ask when to take the first dose of the new medicine relative to your last injection. 2. 2 ### Ask about a starting dose plan Ask whether you will restart titration and what symptoms would pause dose increases. 3. 3 ### Review other medications Ask how the switch affects insulin, sulfonylureas, blood pressure medicines, and diuretics. 4. 4 ### Clarify monitoring and follow-up Ask what side effects should trigger a message, a visit, or urgent care. ## When to see a clinician urgently - ### Severe belly pain Get urgent evaluation for severe, persistent abdominal pain, especially if it radiates to your back or comes with vomiting. This can be a warning sign of pancreatitis or gallbladder disease listed in prescribing information. Do not take another dose until you have been evaluated. - ### Dehydration symptoms Seek care if you cannot keep fluids down, have fainting, confusion, very dark urine, or rapid heartbeat. Vomiting and diarrhea can cause dehydration and worsen kidney function. This is more urgent if you have kidney disease or take diuretics. - ### Allergic reaction Call emergency services for trouble breathing, swelling of the face or throat, or widespread hives. Serious hypersensitivity reactions are possible with injectable medicines. Tell emergency clinicians what you took and when. - ### Low blood sugar signs If you use insulin or a sulfonylurea, get help for confusion, seizures, or loss of consciousness. GLP-1 based medicines can increase hypoglycemia risk when combined with those drugs. Ask your prescriber how to recognize and respond to low blood sugar. ### Do not overlap medicines unless directed Do not take semaglutide and tirzepatide together unless a licensed prescriber specifically instructs you to. Using both can increase side effects and complicate blood sugar management. ## Related treatments [How To Switch From Zepbound To Wegovy](https://www.vitalsvault.com/treatment-learn/how-to-switch-from-zepbound-to-wegovy)[Is Zepbound Better Than Wegovy](https://www.vitalsvault.com/treatment-learn/is-zepbound-better-than-wegovy)[Zepbound Vs Wegovy](https://www.vitalsvault.com/treatment-learn/zepbound-vs-wegovy)[Switching From Ozempic To Mounjaro](https://www.vitalsvault.com/treatment-learn/switching-from-ozempic-to-mounjaro)[Switching From Semaglutide To Tirzepatide](https://www.vitalsvault.com/treatment-learn/switching-from-semaglutide-to-tirzepatide) Treatment options ## See if tirzepatide fits See available options. A qualified clinician must determine whether a prescription treatment is appropriate for you. [See if you qualify](https://treatments.vitalsvault.com/treatments/care-tirzepatide) ## Frequently Asked Questions Is there a switching from Wegovy to Zepbound dosage chart? There is no single official conversion chart between semaglutide (Wegovy) and tirzepatide (Zepbound). Each product has its own FDA labeled titration schedule, and clinicians commonly restart at a lower dose and titrate based on side effects and other medicines. How long should you wait when switching from Wegovy to Zepbound? Both medicines are designed for once weekly dosing, and clinicians often time the first dose of the new medicine around when the next dose would be due. The best timing depends on your symptoms, missed doses, and other medications, so your prescriber should set the plan. Can you take Wegovy and Zepbound together during a switch? Do not use semaglutide and tirzepatide together unless a licensed prescriber specifically instructs you to. Overlap can increase gastrointestinal side effects and complicate blood sugar management, especially if you also use insulin or sulfonylureas. What side effects are most common right after switching? Nausea, vomiting, diarrhea, constipation, and abdominal pain are common when starting or increasing GLP-1 based medicines. Symptoms are often most noticeable during titration and may improve as your body adjusts. Contact a clinician if you cannot keep fluids down or symptoms are severe. If I use compounded versions, is switching different? Yes. Compounded medications are prepared by a licensed pharmacy for an individual prescription and are not FDA-approved, so instructions come from your prescriber and dispensing pharmacy rather than an FDA label. Vitals Vault offers compounded tirzepatide and compounded semaglutide, not the brand products Zepbound or Wegovy. 4.6 out of 5 A little extra for your next check-in. ## Claim a free lab test - Retest an eligible test from your first order - Use on an eligible test within six months By claiming, you agree to receive emails from Vitals Vault. No card needed. [Offer terms](https://www.vitalsvault.com/retest-offer-terms) --- Canonical HTML: https://www.vitalsvault.com/treatment-learn/switching-from-zepbound-to-wegovy - [llms.txt](https://www.vitalsvault.com/llms.txt) - [sitemap.xml](https://www.vitalsvault.com/sitemap.xml) - [Developer portal](https://www.vitalsvault.com/developers)